← Evidence map

ReviewCancer biology & medicine2014

Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond.

Niki Karachaliou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25364578